Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Pharmacoeconomics - Open|January 10, 2024
A Systematic Literature Review of Health-Related Quality of Life Outcomes and Associated Utility Values in Relapsed and/or Refractory Large B Cell LymphomaFei Fei Liu, Meaghan Bartlett, Samantha CraigieJournal of Clinical Epidemiology|August 27, 2018
Certainty ranges facilitated explicit and transparent judgments regarding evidence credibilityKari A O Tikkinen, Samantha Craigie, Holger J Schünemann, et al.Pain Medicine (Malden, Mass.)|May 5, 2018
Hormone Replacement Therapy and Opioid Tapering for Opioid-Induced Hypogonadism Among Patients with Chronic Noncancer Pain: A Systematic ReviewMahmood AminiLari, Priya Manjoo, Samantha Craigie, et al.The Oncologist|November 26, 2024
Systematic literature review and meta-analysis of health state utility values in metastatic castration-resistant prostate cancerElena Castro, Rhett Figliuzzi, Sarah Walsh, et al.The Oncologist|October 19, 2024
Comparative efficacy and safety of talazoparib plus enzalutamide and other first-line treatments for metastatic castration-resistant prostate cancerElena Castro, Jenna Ellis, Samantha Craigie, et al.Future Oncology (London, England)|March 6, 2025
Matching-adjusted indirect comparison of talazoparib plus enzalutamide versus abiraterone acetate and docetaxel in mCRPCElena Castro, Di Wang, Sarah Walsh, et al.Thrombosis Research|July 5, 2015
Adherence to mechanical thromboprophylaxis after surgery: A systematic review and meta-analysisSamantha Craigie, Johnson F Tsui, Arnav Agarwal, et al.Prostate Cancer and Prostatic Diseases|December 7, 2024
Talazoparib plus enzalutamide versus olaparib plus abiraterone acetate and niraparib plus abiraterone acetate for metastatic castration-resistant prostate cancer: a matching-adjusted indirect comparisonElena Castro, Di Wang, Sarah Walsh, et al.Dermatology and Therapy|September 21, 2022
Unmet Need in People with Psoriasis and Skin of Color in Canada and the United StatesGeeta Yadav, Jensen Yeung, Yvette Miller-Monthrope, et al.BMC Medical Genomics|May 25, 2016
Attitudes to incorporating genomic risk assessments into population screening programs: the importance of purpose, context and deliberationStuart G Nicholls, Holly Etchegary, June C Carroll, et al.Pageof 4